why choose us

First received: November 25, 2022

Clinical Trial: A Single-center, Randomized, Double-blinded, Placebo-controlled, Phase 1 Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of NCP112

Study Status: Completed

Recruit Status: Completed

Condition: Atopic Dermatitis

Study Type: Interventional


Official Title: Phase 1 Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of NCP112

Brief Summary: To evaluate safety, tolerability and pharmacokinetics of NCP 112 after single and multiple applications on the skin of healthy male volunteers.

Read more